LPD-824 |
| Clinical data |
|---|
| Other names | LPD-824, N-Pyrrolidyl-lysergamide |
|---|
Routes of
administration | Oral |
|---|
| Pharmacokinetic data |
|---|
| Metabolism | Hepatic |
|---|
| Excretion | Renal |
|---|
| Identifiers |
|---|
IUPAC name (8β)-6-Methyl-8-(pyrrolidin-1-ylcarbonyl)-9,10-didehydroergoline
|
| CAS Number | |
|---|
| PubChem CID | |
|---|
| ChemSpider | |
|---|
| ChEMBL | |
|---|
| CompTox Dashboard (EPA) | |
|---|
| Chemical and physical data |
|---|
| Formula | C20H23N3O |
|---|
| Molar mass | 321.424 g·mol−1 |
|---|
| 3D model (JSmol) | |
|---|
SMILES O=C(N1CCCC1)[C@@H]4C=C3c5cccc2c5c(c[nH]2)C[C@H]3N(C4)C
|
InChI InChI=1S/C20H23N3O/c1-22-12-14(20(24)23-7-2-3-8-23)9-16-15-5-4-6-17-19(15)13(11-21-17)10-18(16)22/h4-6,9,11,14,18,21H,2-3,7-8,10,12H2,1H3/t14-,18-/m1/s1  Key:SETDYMMXQQXCRP-RDTXWAMCSA-N
|
| (verify) |
N-Pyrrolidyllysergamide (LPD-824) is a derivative of ergine. It is reported to have some mild, short lasting LSD-like effects at a dose of 800 micrograms.[1]
References
This article is copied from an
article on Wikipedia® - the free encyclopedia created and edited by its online user community. The text was not checked or edited by anyone on our staff. Although the vast majority of Wikipedia® encyclopedia articles provide accurate and timely information, please do not assume the accuracy of any particular article. This article is distributed under the terms of
GNU Free Documentation License.
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.
)
